News

Pharmabiz47m
Addex Therapeutics leads CHF 2 million investment in Stalicla to advance precision medicine in neuropsychiatric disorders
Addex Therapeutics leads CHF 2 million investment in Stalicla to advance precision medicine in neuropsychiatric disorders: Geneva, Switzerland Tuesday, July 1, 2025, 11:00 Hrs [IS ...
Pharmabiz1h
WuXi Biologics introduces next-generation platform WuXiHigh2.0 for high-concentration biologics with protein concentration reaching 230 mg/mL
WuXi Biologics introduces next-generation platform WuXiHigh2.0 for high-concentration biologics with protein concentration reaching 230 mg/mL: Shanghai Tuesday, July 1, 2025, 10:0 ...
Pharmabiz2h
Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy
Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy: Paris Tuesday, July 1, 2025, 09:00 Hrs [IST] The Mini ...
Pharmabiz3h
A N Mohan re-elected president, Antony Tharyan, general secretary as AKCDA tackles expiry settlement debate
Peethaambaran Kunnathoor, Chennai Tuesday, July 1, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia
Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia: Nandita Vijayasimha, Bengaluru Tuesday, July 1, 2025, 08:00 Hrs [IST] The d ...
Pharmabiz3h
DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity
DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity: Gireesh Babu, New Delhi Tuesday, July 1, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...
Pharmabiz3h
STILL A TOOTHLESS TIGER
But, time has now proven that the Revised UCPMP is still a toothless tiger. The DoP has recently reprimanded AbbVie Healthcare India, the Indian arm of global biopharma major AbbVie Inc, for alleged ...
Pharmabiz3h
India’s medical expertise in robotic surgeries draws patients from across the world
India’s medical expertise in robotic surgeries draws patients from across the world: Nandita Vijayasimha, Bengaluru Tuesday, July 1, 2025, 08:00 Hrs [IST] India’s growing expe ...
Pharmabiz12h
Aldeyra Therapeutics gets US FDA’s special protocol assessment agreement letter for its drug candidate, ADX-2191 to treat primary vitreoretinal lymphoma
Aldeyra Therapeutics, Inc, a biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated and metabolic diseases, announced the receipt of a special protocol ...
Pharmabiz18h
Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product
Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product: Oslo, Norway Monday, June 30, 2025, 17:00 Hrs [IST] Navamedic, a Nordic pha ...
Pharmabiz19h
Bone Biologics seeks US patent for bone regeneration technology
Bone Biologics seeks US patent for bone regeneration technology: Burlington, Massachusetts Monday, June 30, 2025, 16:00 Hrs [IST] Bone Biologics Corporation (Bone Biologics), a de ...
Pharmabiz20h
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection: Shanghai Monday, June 30, 2025, 15:00 Hrs [IST] Mabwell, an innovative ...